REACTIVE OXYGEN SPECIES INDUCED NEURODEGENERATION IN ALZHEIMER'S DISEASE

被引:0
作者
Obreshkova, D. [1 ]
机构
[1] Med Univ Sofia, Fac Pharm, Dept Pharmaceut Chem, Sofia, Bulgaria
关键词
oxidative stress; neurodegeneration; Alzheimer's disease; antioxidants;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oxidative stress is caused by an imbalance between the prooxidant and antioxidant systems. In neuropathology of Alzheimer's disease the important markers of oxidative stress in brain are senile plaques, neurofibrillary tangles, protein and nucleic acid oxidation, lipid peroxidation and mitochondrial abnormalities. Amyloid - beta aggregates deposition in brain induces oxidative changes and generation of an oxidative microenvironment. The increased levels of soluble amyloid - beta(1-42) oligomers lead to neurodegeneration, memory deficits and loss of connectivity by causing aberrations in synapse composition, synapse and dendritic loss and abnormalities. Amyloid - beta proteins and mitochondrial oxidative stress cause hyperphosphorylation of tau protein. Soluble hyperphosphorylated tau oligomers disrupt synaptic function and are involved in synapse loss. For pharmacological treatment of Alzheimer's disease the most important drug discovery strategies include application of antioxidants and inhibitors of acethylcholinesterase, gamma - secretase and aggregation of tau protein.
引用
收藏
页码:71 / 82
页数:12
相关论文
共 144 条
  • [1] Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice
    Abdel-Wahab, Basel A.
    Salama, Ragaa H.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 100 (01) : 59 - 65
  • [2] A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease
    Anand, Preet
    Singh, Baldev
    Singh, Nirmal
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (03) : 1175 - 1180
  • [3] Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex
    Ansari, Mubeen A.
    Scheff, Stephen W.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (02) : 155 - 167
  • [4] Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease
    Arlt, S
    Beisiegel, U
    Kontush, A
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (03) : 289 - 294
  • [5] APOE genotype effects on Alzheimer's disease onset and epidemiology
    Ashford, JW
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 23 (03) : 157 - 165
  • [6] Oxidative Stress and Cell Membranes in the Pathogenesis of Alzheimer's Disease
    Axelsen, Paul H.
    Komatsu, Hiroaki
    Murray, Ian V. J.
    [J]. PHYSIOLOGY, 2011, 26 (01) : 54 - 69
  • [7] Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β-amyloid
    Barnham, KJ
    Haeffner, F
    Ciccotosto, GD
    Curtain, CC
    Tew, D
    Mavros, C
    Beyreuther, K
    Carrington, D
    Masters, CL
    Cherny, RA
    Cappai, R
    Bush, AI
    [J]. FASEB JOURNAL, 2004, 18 (10) : 1427 - +
  • [8] Mitochondrial Dysfunction in Neurodegenerative Diseases
    Johri, Ashu
    Beal, M. Flint
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03) : 619 - 630
  • [9] Behl C, 2005, SUB CELL BIOCHEM, V38, P65
  • [10] Presenilin clinical mutations can affect γ-secretase activity by different mechanisms
    Bentahir, M
    Nyabi, O
    Verhamme, J
    Tolia, A
    Horré, K
    Wiltfang, J
    Esselmann, H
    De Strooper, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 96 (03) : 732 - 742